Table 3. Univariate assessment of invasive and non-invasive variables.
Hazard ratio (95% CI) | Univariate p-value | |||
---|---|---|---|---|
Age | 1.01 (0.98-1.03) | 0.6 | ||
Composite physiological index | 1.06 (1.03-1.09) | <0.001 | ||
Male gender | 1.51 (0.95-2.38) | 0.08 | ||
Diagnosis of Idiopathic pulmonary fibrosis | 1.94 (1.21-3.10) | 0.006 | ||
Fibrosis score (Increase by 10%) | 1.37 (1.15-1.63) | <0.001 | ||
Vasodilator treatment | 0.62 (0.40-0.97) | 0.04 | ||
Right heart catheter haemodynamics | ||||
Mean pulmonary artery pressure | 1.00 (0.98-1.03) | 0.7 | ||
Mean pulmonary artery pressure ≥25mmHg | 1.15 (0.68-1.97) | 0.6 | ||
Pulmonary vascular resistance | 1.03 (0.96-1.10) | 0.4 | ||
Cardiac Output | 0.88 (0.73-1.01) | 0.2 | ||
Echocardiography | ||||
Right ventricular systolic pressure | 1.01 (0.99-1.01) | 0.3 | ||
Right atrial area | 1.00 (0.97-1.04) | 0.8 | ||
Pulmonary acceleration time | 1.00 (0.99-1.02) | 0.7 | ||
RV:LVecho | 1.07 (0.71-1.60) | 0.7 | ||
Transannular plane systolic excursion | 0.97 (0.93-1.02) | 0.3 | ||
RV Fractional area change | 1.01 (0.98-1.04) | 0.5 | ||
CT Pulmonary Angiography | ||||
MPA diameter (per 1mm increase) | 1.01 (0.96-1.06) | 0.7 | ||
MPA diameter (>32mm) | 1.50 (0.93-2.43) | 0.1 | ||
MPADiameter:Aorta ratio | 0.97 (0.84-1.13) | 0.7 | ||
RV subjectively larger than LV | 2.08 (1.16-3.74) | 0.01 | ||
RV:LVaxial ratio | 1.04 (0.99-1.07) | 0.1 | ||
RV:LVaxial ratio ≥ 1.0 | 2.17 (1.19-3.97) | 0.01 | ||
RV:LVlargest ratio | 1.06 (1.01-1.11) | 0.02 | ||
RV:LVlargest ratio ≥ 1.0 | 3.26 (1.49-7.15) | 0.003 | ||
Ventricular septal bowing | 1.30 (0.81-1.96) | 0.3 | ||
RAtransverse | 1.01 (0.99-1.03) | 0.3 | ||
RAlongitudinal | 1.02 (0.99-1.05) | 0.09 |
Abbreviations: As per table 2.